Skip to main content
. 2026 Oct 19;41:e416226. doi: 10.1590/acb416226

Table 3. Multivariable linear regression analysis for determining the difference in serum hemoglobin level between tranexamic acid and placebo groups.

Variable Unstandardized coefficients p -value 95% confidence interval for beta
Beta Standard error Lower bound Upper bound
Tranexamic acid use 0.448 0.127 0.038 0.224 0.750
Female gender 2.725 0.273 0.064 -0.745 6.194
Age -0.148 0.037 0.157 -0.619 0.323
Body mass index 0.043 0.025 0.335 -0.275 0.362
History of hypertension 1.147 0.185 0.102 -1.204 3.497
History of diabetes -0.294 0.053 0.113 -0.965 0.377
History of hyperlipidemia 0.363 0.039 0.068 -0.132 0.858
Current smoking 0.143 0.021 0.092 -0.122 0.409
Serum hemoglobin 0.075 0.026 0.215 -0.260 0.410
White blood count 0.120 0.012 0.065 -0.035 0.275
Platelet count -0.766 0.151 0.124 -2.688 1.157
Fasting blood sugar, -0.211 0.035 0.105 -0.657 0.234
Fasting high-density lipoprotein 0.112 0.019 0.109 -0.134 0.357
Serum creatinine 0.057 0.054 0.372 -0.089 0.226

R square = 0.399; adjusted R square = 0.217. Source: Elaborated by the authors.